Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression
Isoliquiritigenin (ISL) is a flavonoid isolated mainly from the licorice plant, a traditional Chinese herb. ISL has shown anticancer, anti-inflammatory, antioxidant, and antidiabetic activities. However, the pharmaceutical effects of ISL on atherosclerosis are seldom explored. In this study, we used...
Main Authors: | Jie Qi, Jianguo Cui, Baobin Mi, Xiaohong Yan, Wenwen Xu, Hui Ma, Qingtan Zhang, Fang Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2020-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2020/1926249 |
Similar Items
-
TRPC5 ion channel in atherosclerosis : health or disease
by: Al Shawaf, Eman M. M. A. A. M. A.
Published: (2009) -
miR-26a inhibits atherosclerosis progression by targeting TRPC3
by: Min Feng, et al.
Published: (2018-01-01) -
Conserved gating elements in TRPC4 and TRPC5 channels
by: Abdulmughni, A., et al. -
Inhibition of diacylglycerol-sensitive TRPC channels by synthetic and natural steroids.
by: Susanne Miehe, et al.
Published: (2012-01-01) -
Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain.
by: Melissa A Fowler, et al.
Published: (2007-06-01)